***PRESS CALL ON MONDAY, OCTOBER 25 AT 11:30 AM ET***
PRESS CALL: Rep. Peter Welch (D-VT) Joins Experts and Advocates to Urge Congress Not to Eviscerate Medicare Negotiations in Build Back Better Act
Washington, DC — On Monday, October 25 at 11:30 AM ET, Hart Research’s Geoff Garin, Brookings Institution’s Dr. Richard Frank, and Patients for Affordable Drugs’ David Mitchell will join Rep. Peter Welch (D-VT-AL) and Protect Our Care to discuss the latest political situation in Washington as Congress works to pass budget reconciliation legislation and to sound the alarm of the potential consequences of Congress passing a completely watered-down version of Medicare negotiations in the Build Back Better Act.
President Biden and patient advocates are fighting tirelessly to pass historic health care investments as part of the Build Back Better Act, including giving Medicare real power to negotiate for lower drug prices. However, the fight is not over: Big Pharma and other special interests are ramping up their lobbying and scare tactics to protect profits and lie to the American people. According to recent reporting, Pharma’s friends in Congress are trying to eviscerate Medicare negotiations to the point of being nearly meaningless. Polling shows that the health care provisions are the most popular components of the Build Back Better Act. Americans from across the political spectrum overwhelmingly support allowing Medicare to negotiate prescription drug prices.
U.S. Representative Peter Welch (D-VT-AL)
Geoff Garin, President of Hart Research
Dr. Richard Frank, Director of the USC-Brookings Center Schaeffer Initiative on Health Policy
David Mitchell, President and Founder of Patients for Affordable Drugs
Leslie Dach, Chair of Protect Our Care
WHAT: Rep. Peter Welch (D-VT) Joins Experts and Advocates to Urge Congress Not to Water Down Medicare Negotiations in Build Back Better Act
WHERE: Register for the Event Here
WHEN: Monday, October 25 at 11:30 AM ET // 10:30 AM CT